Épimède, what about us ?

Épimède capital is a private fund (PRICAF under Belgian law). It aims to invest in private capital, non-listed, of high-growth technological SMEs. Our strategy focuses on promising companies in early stage phase whose growth potential is demonstrated or in effective growth. Funds raised have to be invested in priority in the financing of growth accelaration.

We give priority to partners we can bring a real added-value in terms of growth support. As such, Épimède will play an active role within the Board of Directors of the target company and will take part in the control of key, strategic decisions.

The amounts raised from Épimède have to be mainly attributed to the subscribtion of new equity.

We are supporting the best and most ambitious entrepreneurs. The Épimède team has a strong experience in terms of strategy and business development of a technological nature. His passion is to work with entrepreneurs Épimède is partnering with in order to build a coherent business vision with an ambitious growth strategy, realistic and in line with means.

Our support is based on solid expert and experience but also on a well-developed network of contacts. This support will potentially be useful to help our entrepreneurs to refine their strategy related to key activities, product positioning, services, production, financing, marketing, recruitment, intellectual property management and internationalization.

Our approach is based on a constructive dialogue and positive challenge.

Participations

 

Working

Investment criteria

Amounts

The amount per investment is:

  • Minimum 1.000.000 € (One million euros);
  • Maximum 7.000.000 € (7 million euros).

Global amount invested in each project will not exceed 33 % (thirty three percent) of the subscribed capital amount increased by amounts given by shareholders, that is to say all means that are made available by Épimède.

Participations profile

Company localization

We give priority to companies which have their head office or main operational office in Wallonia.

Company size

Companies, at the time of initial investment, must (a) have less than 500 (five hundred) employees, (b) net capital assets in the balance sheet which are not exceeding 75.000.000 € (seventy-five million euros) and (c) be self-employed, that is to say not being hold up to a limit of more than 33 % (thirty three percent) by a non-SME.

Company sector

Privileged sectors concern life sciences (Biology, Biotechnology, MedTech, etc), engineering sciences (NTIC and Cleantech) and corporate services. The company has to, in all circumstances, present a competitive advantage in terms of technology or industry.

Financial situation of the company

The company has to:

  • Present a recurrent turnover superior to 1.000.000 € (a million euros), excepted for companies active in the sector of life sciences;
  • Have reached the Break-even (ideally demonstrated profitability and positive cash-flows), excepted for companies active in the sector of life sciences.

Company management

The target company must have management tools at its disposal. Management and shareholders of the target company have to be able to demonstrate an opening to a growth strategy, it particularly concerns:

  • Definition of a 3 to 5-year strategic plan (three to five) in cooperation between the company management and Épimède and agreement concerning financing requirement;
  • Opening of the existing shareholders to dilution.

Agreement on the principle of a possible evolution of the managerial team composition.

We have the deep conviction that a successful partnership is based on shared values and common vision. This is essential in any entrepreneurial venture, inherently uncertain, which will experience its bifurcations, falls, opportunities which will necessitate making frequent, fast and serene decisions.

That is why all our investment decisions are made on a basis of dialogue and exchange. Our decision process is organized as follow:

  1. At first, we invite entrepreneurs to check that their company and project correspond to our investment criteria. We will not take into account any solicitation that would not respect these criteria;
  2. Then, we invite entrepreneurs to communicate a short document (type executive summary), which brings parts of the answer to the following questions:
    • What is your story (Your story and your company’s story)?
    • What specific need of the market are you focusing on?
    • What solution do you propose?
    • Why is this solution unique or differentiated against other existing solutions on the market?
    • How do you estimate your company’s development potential?
    • How much money are you looking for?
    • What for will you use these amounts?
  1. We will then organize a first meeting with our team in order to better know each other;
  2. If this interest is confirmed, a business plan will be validated by common consent to clarify the partnership’s goals and ambition;
  3. A termsheet will be defined in order to clarify the main points of a potential partnership. This termsheet will specify the nature of additional detailed analysis (due diligence) that will be asked;
  1. Once these analyses are complete, if they confirm the fit, an investment proposal will be made at the Board of Director of Épimède;
  2. We invest in your project.

Our team is really flexible and reactive. That means we can make decisions really quickly. Therefore, the decision-making process duration will mainly depend on the following points:

  • A clear (and shared) vision of ambition and growth-strategy since the start of our contacts;
  • A pre-existing business plan, in tune with this vision;
  • A termsheet negotiated in a trustworthy atmosphere;
  • A due diligence made in full collaboration and transparency.

We are supporting the best and most ambitious entrepreneurs. The Épimède team has a strong experience in terms of strategy and business development of a technological nature. His passion is to work with entrepreneurs Épimède is partnering with in order to build a coherent business vision with an ambitious growth strategy, realistic and in line with means.

Our support is based on solid expert and experience but also on a well-developed network of contacts. This support will potentially be useful to help our entrepreneurs to refine their strategy related to key activities, product positioning, services, production, financing, marketing, recruitment, intellectual property management and internationalization.

Our approach is based on a constructive dialogue and positive challenge.

Contact

ÉPIMÈDE

(PRIVATE PRICAF UNDER BELGIAN LAW), limited company.
BCE 634.750.380, RPM Liège

ADDRESS (HEAD OFFICE)

Rue Lambert-Lombard 3 à 4000 Liège

PHONE

+32 (0)4 221 62 21

EMAIL ADDRESS

info@epimede.be

FORMULAIRE DE CONTACT